Search
                    Massachusetts Paid Clinical Trials
A listing of 3204  clinical trials  in Massachusetts  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            2653 - 2664 of 3204
        
                Massachusetts is currently home to 3204 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Boston, Worcester, Springfield and Burlington. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
                                
            
            
        Recruiting
                            
            
                To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications).
This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked...  Read More             
        
        
    Gender:
                ALL
            Ages:
                65 years and above
            Trial Updated:
                08/28/2024
            
            Locations: Joslin Diabetes Center, Boston, Massachusetts         
        
        
            
        
    
                
                                    REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
                                
            
            
        Recruiting
                            
            
                A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1.             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                08/27/2024
            
            Locations: University of Massachusetts Chan Medical School, Worcester, Massachusetts         
        
        
            Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Platinum-resistant Ovarian Cancer
        
            
        
    
                
                                    Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/27/2024
            
            Locations: Massachusetts General Hospital, Boston, Massachusetts         
        
        
            Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin's
        
            
        
    
                
                                    CLOZAPINE Response in Biotype-1
                                
            
            
        Recruiting
                            
            
                The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as psychosis control with risperidone as medication control. The study is designed to evaluate effect of clozapine on the B1 participants, and the effect that will be evaluated is a biomedical outcome. The...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 60 years
            Trial Updated:
                08/27/2024
            
            Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts         
        
        
            Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder
        
            
        
    
                
                                    Utilizing Battlefield Acupuncture to Treat Chronic Pain
                                
            
            
        Recruiting
                            
            
                This research study will evaluate the effectiveness of utilizing Battlefield Acupuncture (BFA) on veterans with with a history of substance use disorder and chronic pain for 8 weeks.
Primary Aim: The primary aim of this study is to evaluate the effectiveness of using BFA to treat chronic pain in veterans with a history of substance use disorder.
Secondary Aim: This study will also evaluate the impact that BFA treatment for pain may have on subjects' stress, mood and sleep patterns over 8 weeks...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/26/2024
            
            Locations: Bedford VA Healthcare System, Bedford, Massachusetts         
        
        
            Conditions: Chronic Pain, Substance Use Disorders
        
            
        
    
                
                                    Serial MRI Scans During Radiation Therapy
                                
            
            
        Recruiting
                            
            
                This is a phase 1 study to determine the feasibility and utility of using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy (standard of care cancer treatment) for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma.
The research study procedures include three MRI scans (one before, one during, and one after standard of care cancer radiation therapy) for participants with advanced es...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/25/2024
            
            Locations: Brigham and Women Hospital, Boston, Massachusetts         
        
        
            Conditions: Glioblastoma, Esophageal Cancer, Radiotherapy, Magnetic Resonance Imaging, MRI, Prostate Cancer, Vulvar Cancer, Pediatric Glioblastoma Multiforme
        
            
        
    
                
                                    Neurofibromatosis Type 1 Tumor Early Detection Study
                                
            
            
        Recruiting
                            
            
                The goal of this observational study is to determine if a liquid biopsy (i.e. blood test) is an effective clinical tool for monitoring the development of malignant peripheral nerve sheath tumor (MPNST) among adults (18 years and older) with Neurofibromatosis Type 1 (NF1), compared to the current standard of care. The main questions it aims to answer are:
How effective is liquid biopsy compared to the current standard of care (clinical surveillance and imaging) for early detection of MPNST devel...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/23/2024
            
            Locations: Boston Children's Hospital, Boston, Massachusetts         
        
        
            Conditions: Neurofibromatosis Type 1, Neurofibromatosis 1, Plexiform Neurofibroma, Plexiform Neurofibromas, Malignant Peripheral Nerve Sheath Tumor, Malignant Peripheral Nerve Sheath Tumors, Atypical Neurofibroma
        
            
        
    
                
                                    Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System
                                
            
            
        Recruiting
                            
            
                A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 89 years
            Trial Updated:
                08/23/2024
            
            Locations: The Vascular Care Group, Hyannis, Massachusetts         
        
        
            Conditions: Acute Deep Venous Thrombosis of Ileofemoral Vein
        
            
        
    
                
                                    Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms in people with CF that needs medical intervention. Both doctors and CF patients are trying to understand the best way to treat pulmonary exacerbations. This study is trying to answer the following questions about treating a pulmonar...  Read More             
        
        
    Gender:
                ALL
            Ages:
                6 years and above
            Trial Updated:
                08/23/2024
            
            Locations: Boston Children's Hospital, Brigham & Women's Hospital, Boston, Massachusetts         
        
        
            Conditions: Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
        
            
        
    
                
                                    Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
                                
            
            
        Recruiting
                            
            
                Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.             
        
        
    Gender:
                ALL
            Ages:
                12 months and below
            Trial Updated:
                08/22/2024
            
            Locations: Boston Children's Hospital, Boston, Massachusetts         
        
        
            Conditions: Lung Injury, Cardiopulmonary Bypass
        
            
        
    
                
                                    Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery
                                
            
            
        Recruiting
                            
            
                This will be a randomized, placebo-controlled, double-blinded, pilot trial with two parallel groups (1:1 ratio) receiving either dexmedetomidine (initial bolus of 1 mcg/kg over 30 min after induction, followed by an infusion rate of 0.3 mcg/kg/hr that will be stopped 30-45 minutes before the end of the surgery or upon reaching maximum dose of 2mcg/kg, whichever comes first) or placebo (normal saline as a bolus followed by maintenance infusion at the same rate of the intervention group).
Dexmede...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                08/21/2024
            
            Locations: Brigham and Women's Hospital, Boston, Massachusetts         
        
        
            Conditions: Surgery-Complications, Respiratory Complication, Lung Injury, Acute
        
            
        
    
                
                                    Neural Mechanisms of Family-Focused Treatment for Youth Depression
                                
            
            
        Recruiting
                            
            
                The goal of this interventional study is to compare the baseline neural mechanisms and parenting in depressed and non-depressed children and to examine baseline neural mechanisms and parenting as predictors of Family-Focused Treatment for Childhood-Depression (FFT-CD) outcomes. The main questions it aims to answer are:
* What are differences between depressed and non-depressed participants on baseline neural and parenting indicators?
* Do baseline neural and parenting indicators predict respons...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 7 years and 12 years
            Trial Updated:
                08/21/2024
            
            Locations: Boston University, Boston, Massachusetts         
        
        
            Conditions: Childhood Depression
        
            
        
    